Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp.
Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals Lp.
Opinion
NOTE: This order is nonprecedential United States Court of AppeaIs for the FederaI Circuit TEVA PHARMACEUTICAL INDUSTRIES LTD., Plaintiff-Appellan,t, ' V. ASTRAZENECA PHARMACEUTICALS LP AND IPR PHARMACEUTICALS INC., Defen,dan,ts-Appellees.
2011-1091_ ` Appea1 from the United States District Cou1't for the Eastern District of Pennsy1vania in case no. 08-CV-4786, Judge Wi11iam H. Yohn, Jr. ON MOTION ORDER Teva Pharmaceutica1 Industries Ltd. moves for an ex- tension of ti1ne, until May 26, 2011, to file the joint ap- pendix. TeVa also moves to withdraw John L. North, Jeffrey J. Toney, Jonathan K. Waldrop, and Darcy L.
Jones, as counsel of record and to substitute Jeffrey D.
B1ake as principal counsel Upon consideration thereof TEVA PHARMA V. ASTRAZENECA PHARMA CC.
S IT Is ORDERED THAT: The motions are granted Jeffrey D. Blake should promptly file an entry of appearance as principal counsel.
FOR THE COURT l‘lAY 1 9 ?9ll 131 Jan H0rba1y Date J an Horbaly Clerk Jeffrey D. Blake, Esq.
John L. North, Esq. B'S'l`HE'l'!E Darcy L. Jones, ESq §-?.§: §2=~; i’“ §_>Y'= EAL8 FOR RCU1T Jeffrey J. Toney, Esi1. MAY` 1 go Jonathan K. Waldrop, Esq.
Eric Jay Fues, Esq. -lANmRBALY __
Case-law data current through December 31, 2025. Source: CourtListener bulk data.